Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer’s disease mouse model
Rose Chesworth, David Cheng, Chloe Staub, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15

Showing 15 citing articles:

Brain-specific targeted delivery of therapeutic agents using metal–organic framework-based nanomedicine
Zongsu Han, Muzhaozi Yuan, Nguyen Nguyen, et al.
Coordination Chemistry Reviews (2024) Vol. 514, pp. 215926-215926
Closed Access | Times Cited: 8
Cannabidiol (CBD) potentiates physiological and behavioral markers of hypothalamic–pituitary–adrenal (HPA) axis responsivity in female and male mice
Bryan W. Jenkins, Hayley A. Spina, Kate Nicholson, et al.
Psychopharmacology (2025)
Open Access | Times Cited: 1
A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders
Oluwadara Pelumi Omotayo, Yolandy Lemmer, Shayne Mason
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 6
The Effects of Indirect and Direct Modulation of Endocannabinoid System Function on Anxiety-Related Behavior in Mice Assessed in the Elevated Plus Maze Test
Marta Kruk-Słomka, Agnieszka Dzik, Grażyna Biała
Molecules (2025) Vol. 30, Iss. 4, pp. 867-867
Open Access
Persistent behavioural consequences of chronic adolescent cannabidiol (CBD) in a mouse model with increased susceptibility to Δ9-tetrahydrocannabinol and schizophrenia
Gabriela Visini, Rose Chesworth, Tim Karl
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111306-111306
Closed Access
Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease mice
Frederik Wilhelm Ott, Marius E. Sichler, Caroline Bouter, et al.
Journal of Alzheimer s Disease Reports (2025) Vol. 9
Open Access
The role of cannabidiol in aging
Beibei Ni, Yanying Liu, Meng Dai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115074-115074
Open Access | Times Cited: 10
Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer’s Disease Neurodegeneration
Long Chen, Haopeng Sun, Jinran Li, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2672-2672
Open Access | Times Cited: 9
Alzheimer’s disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging
Liu Yan-ying
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Synergetic effect of β-asarone and cannabidiol against Aβ aggregation in vitro and in vivo
Fangyuan Duan, Ting Ju, Chen Song, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3875-3884
Open Access | Times Cited: 2
Canabidiol como opção terapêutica na Doença de Alzheimer
Fabiana Teixeira Aguiar, Jéssica de Vasconcellos Barbosa, Lays Cristina da Silva, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 4, pp. e71245-e71245
Open Access
Chronic Cannabidiol Administration Mitigates Excessive Daytime Sleepiness and Fatigue in Patients with Primary Hypertension: Insights from a Randomized Crossover Trial
Goran Dujić, Marko Kumrić, Josip Vrdoljak, et al.
Cannabis and Cannabinoid Research (2024)
Closed Access
Cannabidiol (CBD) potentiates physiological and behavioral markers of hypothalamic-pituitary-adrenal (HPA) axis responsivity in female and male mice
Bryan W. Jenkins, Hayley A. Spina, Kate Nicholson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The synthetic cannabinoid WIN 55,212-2 attenuates cognitive and motor deficits and reduces amyloid load in 5XFAD Alzheimer mice
Johanna E L Möller, F. Schmitt, Daniel Günther, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 247, pp. 173944-173944
Open Access
A systematic study of molecular targets of cannabidiol in Alzheimer's disease
Nil Patil, Kalpana S. Patil, Mukul Jain, et al.
Journal of Alzheimer s Disease Reports (2024) Vol. 8, Iss. 1, pp. 1339-1360
Open Access
Page 1

Scroll to top